Dason E.S. . .Diagnosis and management of polycystic ovarian syndrome. ” CMAJ, 10(2024) : E85-E94.
Broer S.L. . .AMH: Ovarian reserve testing and its potential clinical implications. ” Human Reproduction Update, 10(2014) : 688-701.
Piltonen .2024 .Validation of an anti-Müllerian hormone cutoff for polycystic ovarian morphology in the diagnosis of polycystic ovary syndrome in the HARMONIA study. e48854. doi:10, 13 : .
Sivanandy M.S.,Ha S.K. . .The role of serum antiMüllerian hormone measurement in the diagnosis of polycystic ovary syndrome. ” Diagnostics, 10(2023) : 907.
Miyake N. . .Association between anti-Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in Japan. e12615. doi:10.1002/rmb2, 23(2024) : 12615.
Marca La,A. La .2006 .Serum anti-Müllerian hormone throughout the human menstrual cycle. ” Human Reproduction, 10(12) : 3103-3107.
Li H.W. .2013 .Variation of anti-Müllerian hormone measurement during the menstrual cycle-A prospective cohort study. ” Fertility and Sterility, 01(2016) : 627-634.
Karkanaki A. . .The clinical significance of antiMüllerian hormone testing in reproductive endocrinology. ” Hormones, 18(2019) : 403-411.
Visser J.A. . .Anti-Müllerian hormone: a new marker for ovarian function. ” Reproduction, 131(2012) : 1-9.
Al-Taee H.A.J.,Al-Sallami S.W. . .Iraqi experience in the assessment of anti-Müllerian hormone utilisation in clinical practice: an overview. Medical Journal of Babylon, 970(2023) : 23-669.
Rashid D.,Bardan D. .2022 .Anti-Müllerian hormone serum level as a predictor of responsiveness to clomiphene citrate therapy in Iraqi women with PCOS. ” Open Access Macedonian Journal of Medical Sciences, 8691 : 1-7.
Alhassan S. .2023 .Diagnostic performance of anti-Müllerian hormone, luteinizing hormone to follicle-stimulating hormone ratio, testosterone, and prolactin to predict polycystic ovary syndrome among Sudanese women. International Journal of Women's Health, 10 : 837-843.
Anand S. . .Updated meta-analysis on the diagnostic accuracy of serum anti-Müllerian hormone in polycystic ovary syndrome involving 13,509 subjects. Journal of Obstetrics and Gynaecology Research, 10(2022) : 2162-2174.
Taylor .2020 .Examining the link between positive affectivity and anxiety reactivity to social stress in individuals with and without social anxiety disorder. ” Journal of Anxiety Disorders, 102264 : 102264.
Zhao Y. .2019 .Diagnostic value of anti-Müllerian hormone as a biomarker for polycystic ovary syndrome: a metaanalysis update. ” Endocrine Practice, 10(10) : 1056-1066.
Van der Ham K. .2024 .Anti-Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis. ” Fertility and Sterility, 05(2024) : 727-739.
Dewailly D. . .The physiology and clinical utility of anti-Müllerian hormone in women. ” Human Reproduction Update, 10(2014) : 370-385.
Tsukui Y. . .Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: A systematic review and meta-analysis. ” Endocrine Journal, 0081(2022) : 897-906.
Aslan Kiper,A. Kiper .2025 .Age-stratified analysis of anti-Müllerian hormone levels and the prevalence of diminished ovarian reserve in women aged 18-45. , 1612194 : 1-10.
Deswal R. .2020 .The prevalence of polycystic ovary syndrome: a brief systematic review. ” Journal of Human Reproductive Sciences, 95 : 18-271.
Hamid M.H.A. . .A randomized controlled trial comparing WALANT to general anesthesia in plating of distal radius fractures. e12876. doi:10, 13(2021) : .
Dehghan E. .2022 .Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd infertility centre: a cross-sectional study. International Journal of Reproductive BioMedicine, 10(12) : 10059-1090.